Personalis, Inc. Operating Lease, Payments
Personalis, Inc. (PSNL) reported Operating Lease, Payments of $3.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-04
- Personalis, Inc. operating lease, payments for the quarter ending 2026-06-30 was $1.80M, a 14.29% decline year-over-year.
- Personalis, Inc. operating lease, payments for the quarter ending 2026-03-31 was $1.80M, a 14.29% decline year-over-year.
- Personalis, Inc. operating lease, payments for the quarter ending 2025-12-31 was $1.90M, a 5.00% decline year-over-year.
- Personalis, Inc. operating lease, payments for the quarter ending 2025-09-30 was $2.00M, a 4.76% decline year-over-year.
- Personalis, Inc. operating lease, payments for fiscal 2025 was $8.10M, a 0.00% change from fiscal 2024.
- Personalis, Inc. operating lease, payments for fiscal 2024 was $8.10M, a 35.00% increase from fiscal 2023.
- Personalis, Inc. operating lease, payments for fiscal 2023 was $6.00M, a 36.36% increase from fiscal 2022.
- Personalis, Inc. operating lease, payments for fiscal 2022 was $4.40M, a 33.33% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.60M 10-Q · filed 2026-08-04 | $5.50M derived: sum of 3 quarters · filed 2026-08-04 | $7.50M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.80M 10-Q · filed 2026-05-07 | $3.70M derived: sum of 2 quarters · filed 2026-05-07 | $5.70M derived: sum of 3 quarters · filed 2026-05-07 | $7.80M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.90M derived: sum of 2 quarters · filed 2026-02-26 | $6.00M derived: sum of 3 quarters · filed 2026-08-04 | $8.10M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.10M derived: sum of 2 quarters · filed 2026-08-04 | $6.20M 10-Q · filed 2025-11-04 | $8.20M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $4.20M 10-Q · filed 2026-08-04 | $6.20M derived: sum of 3 quarters · filed 2026-08-04 | $8.30M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $2.10M 10-Q · filed 2026-05-07 | $4.10M derived: sum of 2 quarters · filed 2026-05-07 | $6.20M derived: sum of 3 quarters · filed 2026-05-07 | $8.20M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.10M derived: sum of 2 quarters · filed 2026-02-26 | $6.10M derived: sum of 3 quarters · filed 2026-02-26 | $8.10M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $4.10M derived: sum of 2 quarters · filed 2025-11-04 | $6.10M 10-Q · filed 2025-11-04 | $8.10M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $4.00M 10-Q · filed 2025-08-05 | $6.00M derived: sum of 3 quarters · filed 2025-08-05 | $7.80M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $2.00M 10-Q · filed 2025-05-06 | $4.00M derived: sum of 2 quarters · filed 2025-05-06 | $5.80M derived: sum of 3 quarters · filed 2025-05-06 | $7.20M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.80M derived: sum of 2 quarters · filed 2025-02-27 | $5.20M derived: sum of 3 quarters · filed 2025-02-27 | $6.00M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $3.20M derived: sum of 2 quarters · filed 2024-11-06 | $4.00M 10-Q · filed 2024-11-06 | $5.10M derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.20M 10-Q · filed 2024-08-07 | $3.30M derived: sum of 3 quarters · filed 2024-08-07 | $4.70M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $800.00K 10-Q · filed 2024-05-08 | $1.90M derived: sum of 2 quarters · filed 2024-05-08 | $3.30M derived: sum of 3 quarters · filed 2024-05-08 | $4.30M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.50M derived: sum of 2 quarters · filed 2024-02-28 | $3.50M derived: sum of 3 quarters · filed 2024-02-28 | $4.40M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.40M derived: sum of 2 quarters · filed 2023-11-07 | $3.30M 10-Q · filed 2023-11-07 | $4.30M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.90M 10-Q · filed 2023-08-08 | $2.90M derived: sum of 3 quarters · filed 2024-02-28 | $3.80M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $900.00K 10-Q · filed 2023-05-03 | $1.90M derived: sum of 2 quarters · filed 2024-02-28 | $2.80M derived: sum of 3 quarters · filed 2024-02-28 | $3.60M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.90M derived: sum of 2 quarters · filed 2024-02-28 | $2.70M derived: sum of 3 quarters · filed 2024-02-28 | $3.30M 10-K · filed 2024-02-28 |
| 2021-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $1.70M derived: sum of 2 quarters · filed 2022-11-02 | $2.30M 10-Q · filed 2022-11-02 | $2.80M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.40M 10-Q · filed 2022-08-03 | $1.90M derived: sum of 3 quarters · filed 2023-02-23 | $2.30M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $600.00K 10-Q · filed 2022-05-04 | $1.10M derived: sum of 2 quarters · filed 2023-02-23 | $1.50M derived: sum of 3 quarters · filed 2023-02-23 | $1.90M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $900.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.30M derived: sum of 3 quarters · filed 2023-02-23 | $1.70M 10-K · filed 2023-02-23 |
| 2020-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $800.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.20M 10-Q · filed 2021-11-04 | $1.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $800.00K 10-Q · filed 2021-08-04 | $1.20M derived: sum of 3 quarters · filed 2022-02-24 | $1.50M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $400.00K 10-Q · filed 2021-05-05 | $800.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.10M derived: sum of 3 quarters · filed 2022-02-24 | $1.30M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $700.00K derived: sum of 2 quarters · filed 2022-02-24 | $900.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.20M 10-K · filed 2022-02-24 |
| 2019-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $500.00K derived: sum of 2 quarters · filed 2020-11-05 | $800.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $500.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $300.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |